Your Best Stock
$151.03
−$0.34 (-0.22%)
Market open · Sep 24, 2:00 pm ET
After hours $151.37 0.00%
Open$151.10
Prev close$151.37
Day range$149.69 – $152.97
Volume2.55M
Market cap$187.27B
P/E (TTM)–
Dividend yield2.13%

Earnings

Average move on report day±4.4%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+12.9%
Worst reaction-4.2%

Stock move on the day after each report

-3.4%2023/Q3-4.2%2023/Q4+0.2%2024/Q1-2.6%2024/Q2+6.8%2024/Q3+7.5%2024/Q4-2.8%2025/Q1+8.3%2025/Q2+1.1%2025/Q3+5.8%2025/Q4-2.0%2026/Q1-2.6%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026After Market±6.8%-2.58%Within range
2026/Q17 May 2026After Market±7.3%-2.04%Within range
2025/Q410 Feb 2026After Market±7.6%+5.82%Within range
2025/Q330 Oct 2025After Market±7.9%+1.14%Within range
2025/Q27 Aug 2025After Market±7.7%+8.28%Bigger than priced
2025/Q124 Apr 2025After Market±6.0%-2.81%Within range
2024/Q411 Feb 2025–±4.5%+7.46%Bigger than priced
2024/Q36 Nov 2024After Market±3.7%+6.77%Bigger than priced
2024/Q28 Aug 2024After Market±4.0%-2.55%Within range
2024/Q125 Apr 2024After Market±3.0%+0.23%Within range
2023/Q46 Feb 2024After Market±3.1%-4.25%Bigger than priced
2023/Q37 Nov 2023After Market±3.0%-3.36%Bigger than priced
2023/Q23 Aug 2023After Market±3.3%+4.17%Bigger than priced
2023/Q127 Apr 2023After Market±3.8%-1.60%Within range
2022/Q42 Feb 2023After Market±4.2%+3.82%Within range
2022/Q327 Oct 2022After Market±3.1%+12.92%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Biktarvy$3.77B 48.3%
  • Descovy$967.00M 12.4%
  • Other$909.00M 11.6%
  • Trodelvy$457.00M 5.9%
  • Yescarta$346.00M 4.4%
  • Sofosbuvir/Velpatasvir$303.00M 3.9%
  • Vemlidy$289.00M 3.7%
  • Genvoya$289.00M 3.7%
  • Odefsey$239.00M 3.1%
  • Yeztugo$232.00M 3.0%

Latest reported quarter: Q2, ended Jun 2026

Revenue$7.80B+10.2% YoY
Operating profit$2.54B-6.8% YoY
Net profit-$10.50B-635.5% YoY
Diluted EPS-$8.45-641.7% YoY
Free cash flow$3.43B+376.8% YoY
Operating cash flow$3.57B

Revenue, last 8 quarters

$7.5BSep '24$7.6BDec '24$6.7BMar '25$7.1BJun '25$7.8BSep '25$7.9BDec '25$7.0BMar '26$7.8BJun '26

Net profit, last 8 quarters

$1.3BSep '24$1.8BDec '24$1.3BMar '25$2.0BJun '25$3.1BSep '25$2.2BDec '25$2.0BMar '26$-10.5BJun '26

Profitability & balance sheet

Gross margin79.6%
Operating margin38.5%
Net margin-10.6%
Return on equity-20.6%
Return on assets-6.2%
Return on invested capital-6.9%
Current ratio1.27
Liabilities / assets76.2%
Cash & investments$3.18B
Total debt$26.25B
Net cash (debt)-$23.07B
Free cash flow / sales42.5%
Scroll to Top